Analystreport

Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.50 price target on the stock.

Osmotica Pharmaceuticals plc - Ordinary Shares  (OSMT) 
Last osmotica pharmaceuticals plc - ordinary shares earnings: 3/18 04:05 pm Check Earnings Report